How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.

Abstract

Good compliance is vitally important. The value of a fourth drug in the initial phase of chemotherapy in preventing resistance is questioned. An explanation for mono-resistance to rifampicin in patients with the acquired immune deficiency syndrome (AIDS) is suggested.